You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 25 No. 4, October 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

Raffaello Papeschi, MD, MSc; David J. McClure, MD, MSc

Arch Gen Psychiatry. 1971;25(4):354-358.


Abstract

The concentration of homovanillic acid (HVA) in the lumbar cerebrospinal fluid (CSF) of 18 patients with endogenous depression was significantly lower than that of 18 neurological controls not affected by extrapyramidal diseases, epilepsy, senile or presenile dementia. The 5hydroxyindoleacetic acid (5-HIAA) was also decreased in the depressed group but not significantly so. These data support the concept of an involvement of dopamine metabolism in affective disorders. After one week of treatment with dexamethasone (0.75 mg, daily) no significant change was observed in HVA or 5-HIAA levels in the CSF; after two weeks of imipramine hydrochloride (50 mg, three times a day) 5-HIAA, but not HVA, was significantly reduced. No negative correlation was found between levels of HVA or 5HIAA and scores on the Hamilton and Beck Rating scales for various symptoms of depression. Age was also not correlated with HVA or 5HIAA.



Author Affiliations

Montreal

From the Laboratory of Chemical Neurobiology, Department of Psychiatry, McGill University (Dr. Papeschi), the Montreal General Hospital, and the Department of Psychiatry, McGill University, Montreal (Dr. McClure). Dr. Papeschi is a fellow of the Medical Research Council of Canada.


Footnotes

Accepted for publication Feb 22, 1971.

Read before the 13th meeting of the Psychiatric Research Society (Group Without a Name), Montreal, Oct 17, 1970.

Reprint requests to Laboratory of Chemical Neurobiology, Allan Memorial Institute of Psychiatry, 1033 Pine Ave West, Montreal 112, PQ (Dr. Papeschi).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Human Platelet: A Diagnostic and Research Tool for the Study of Biogenic Amines in Psychiatric and Neurologic Disorders
Stahl
Arch Gen Psychiatry 1977;34:509-516.
ABSTRACT  

Homovanillic Acid and 5-Hydroxyindoleacetic Acid Cerebrospinal Fluid Levels: A Study With and Without Probenecid Administration of Their Relationship to the State of Consciousness After Head Injury
Vecht et al.
Arch Neurol 1975;32:792-797.
ABSTRACT  

Inhibition of Dopamine-B-Hydroxylase in Manic Patients: A Clinical Trial With Fusaric Acid
Sack and Goodwin
Arch Gen Psychiatry 1974;31:649-654.
ABSTRACT  

Central Dopamine Turnover in Schizophrenic Syndromes
Bowers
Arch Gen Psychiatry 1974;31:50-54.
ABSTRACT  

Effects of Amitriptyline and Imipramine on Amine Metabolites in the Cerebrospinal Fluid of Depressed Patients
Post and Goodwin
Arch Gen Psychiatry 1974;30:234-239.
ABSTRACT  

Cerebral Monoamines and Depression: An Investigation With the Probenecid Technique
van Praag and Korf
Arch Gen Psychiatry 1973;28:827-831.
ABSTRACT  

Central Monoamine Metabolism in Parkinson's Disease
Chase and Ng
Arch Neurol 1972;27:486-491.
ABSTRACT  

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients
Mendels et al.
Science 1972;175:1380-1382.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.